Kevin Marks, Founder of Delphia Therapeutics

Kevin Marks is the founder of Delphia Therapeutics. Delphia Therapeutics has raised $67M, latest Series A $67M (2024). Biotech · Cambridge, MA.

About Kevin Marks

Kevin Marks is the founder of Delphia Therapeutics. Delphia Therapeutics operates in Biotech and is based in Cambridge, MA. Delphia Therapeutics has raised $67M, latest Series A $67M (2024). Backers on record include Dave Barrett, Jon Flint, Polaris Partners.

Kevin Marks at a glance

Company
Delphia Therapeutics
Industry
Biotech
Location
Cambridge, MA
Total raised
$67M
Investors on record
Dave Barrett, Jon Flint, Polaris Partners

Frequently asked about Kevin Marks

Who is Kevin Marks?
Kevin Marks is the founder of Delphia Therapeutics. Full profile, funding history and background on StartupFundraising.com.
What company did Kevin Marks found?
Kevin Marks founded Delphia Therapeutics, a Biotech company based in Cambridge, MA.
How do I contact Kevin Marks?
Verified contact routes including LinkedIn, background and funding history for Kevin Marks are available on the StartupFundraising.com founder profile.

This founder profile draws on disclosed rounds, filings and investor records in the StartupFundraising database and is updated as new funding is recorded. Founders raising now use profiles like this one to study comparable Biotech journeys in Cambridge — who backed them, at what stage, and how much they raised.

Delphia Therapeutics funding profile (1)

More Biotech founders (40)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library